Bill of Lading No.
Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
BOAE2203034
2022-04-07
300449 C?NG TY TNHH Y T? VIMEDLINK ENTOD PHARMACEUTICALS LTD Small eye solution Myatro, B.No. HE6167, 1 bottle of 5ml/box, indicated to slow down the near -sighted development of children, active ingredients: Atropine sulphate 0.01%, NSX: Hanuchem Laboratories, Exp.dt: 11/2024, 100%new;Dung dịch nhỏ mắt Myatro, B.NO. HE6167, 1 lọ 5ml/hộp, chỉ định để làm chậm qt tiến triển cận thị ở trẻ em, hoạt chất: Atropine Sulphate 0.01%, nsx: Hanuchem Laboratories, EXP.DT: 11/2024, mới 100%
INDIA
VIETNAM
MUMBAI(EX BOMBAY)
HA NOI
44
KG
1200
UNK
1680
USD
BOAE2203034
2022-04-07
300449 C?NG TY TNHH Y T? VIMEDLINK ENTOD PHARMACEUTICALS LTD Myatro-XL small eye solution, B.NO. HE6168, 1 bottle of 5ml/box, indicated to slow down the near -sighted development of children, active ingredients: Atropine sulphate 0.05%, NSX: Hanuchem Laboratories, Exp.dt: 11/2024, 100%new;Dung dịch nhỏ mắt Myatro-XL, B.NO. HE6168, 1 lọ 5ml/hộp, chỉ định để làm chậm qt tiến triển cận thị ở trẻ em, hoạt chất: Atropine Sulphate 0.05%, nsx: Hanuchem Laboratories, EXP.DT: 11/2024, mới 100%
INDIA
VIETNAM
MUMBAI(EX BOMBAY)
HA NOI
44
KG
1100
UNK
1848
USD
MAEU218449289
2022-06-08
620600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 14 PALLETS 761 CARTONS PH ARMACEUTICALS AS UNDER ESOM EPRAZOLE MAG DR CAPS 20MG 90 S NDC CODE:68462039090 FDA PR ODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 A NDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL H YPERSECRETORY CONDITIONS, INC LUDING ZOLLINGER-ELLISON SYN DROME ESOMEPRAZOLE MAG DR C APS 40MG 90 S NDC CODE:684620 39190 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004 .90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOL E MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR T HE LONG-TERM TREATMENT OF PA THOLOGICAL HYPERSECRETORY CO NDITIONS, INCLUDING ZOLLINGER -ELLISON SYNDROME COMMERCI AL & CUSTOM INVOICE NO. F2238 7000139 DT. 29.04.2022 S/BILL NO: 4006221 DT: 29/04/2022 NET WT: 756.17 KGS 14 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3034
KG
14
PKG
0
USD
KWLD70330040536
2021-02-06
624900 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 01 X 40 RF CNTR TOTAL 41 (FORTY ONE) PACKAGESTS 500MG 500 S NDC CODE68462019005 FDA PRODU CT CODE NO.-62 G C A 49 H. T. S NO.<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8718
KG
41
PKG
0
USD
MAEU216792167
2022-03-24
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 3858 CARTONS PACKED IN 46 PALLETS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC PRAMIPEXOLE TABS 1M G 90 S NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S DI SEASE PRAMIPEXOLE TABS 0.25MG 90 S NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:68462033290 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTIC E USE: USED IN PARKINSON#S DIS EASE OXCARBAZEPINE TABLETS 30 0MG 100 S NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AGE NT OLMESARTAN MEDOXOMIL TABLE TS 5MG 30 S NDC CODE:68462043 630 FDA PRODUCT CODE NO.: 62C CA68 H. T. S NO.: 3004.90.922 0 ANDA NO.: 203281 THERAPEUTI CE USE: -TREATMENT OF HYPERTEN SION, ALONE ORWITH OTHER ANTI HYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE POTASSIUM CL ER TAB 20MEQ (1500MG) 500 S N DC CODE:68462047205 FDA PRODU CT CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA NO. : 206391 THERAPEUTICE USE: - MEDICATION USED FOR HEART FAIL URE, HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART URSODIOL TABS 2 50MG 100 S NDC CODE:684620473 01 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 90-801 THERA PEUTICE USE: - FOR THE TREATME NT OF PATIENTS WITH PRIMARY B ILIARY CIRRHOSIS GABAPENTIN TABLETS 600MG 100 S NDC CODE: 68462012601 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICON VULSANT AGENT NET WT : 10,381 .95 KGS GROSS WT : 12,463.41 KGS COMMERCIAL & CUSTOM INVOI CE NO. F22252005778 DT. 23.02 .2022 F22252005780 DT. 23.02. 2022 SB NO.: 8492215 DT.: 24/ 02/22 SB NO.: 8492102 DT.: 24 /02/22 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12464
KG
46
PKG
0
USD
MAEU216471582
2022-03-09
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER 49 PACKAGE CONSISTING OF 3295 CARTONS PH ARMACEUTICALS AS UNDER NAPROX EN TABLETS 500MG 100 S NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC N APROXEN TABLETS 500MG 500 S N DC CODE:68462019005 FDA PRODU CT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE US E:-ANTI-INFLAMMATORY, ANALGES IC CARVEDILOL TABS 6.25MG 500 S NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST TOPIRAMATE TABLET S 25MG 60 S NDC CODE:68462010 860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 T HERAPEUTICE USE:-ANTICONVULSA NT GABAPENTIN TABLETS 600MG 5 00 S NDC CODE:68462012605 FD A PRODUCT CODE NO: 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.:91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE 03 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE NO. F222520055 51 DT. 05.02.2022 F2225200555 2 DT. 05.02.2022 F22252005553 DT. 05.02.2022 TOTAL NET.WT. :11610.44KGS SBILL NOS DT. 8053058 07-FEB-2022 80532 61 07-FEB-2022 8053408 07- FEB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
13478
KG
49
PKG
0
USD
MAEU214106719
2021-11-18
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LTD 1X 40 REEFER FCL 41 PALLETS CONSISTING OF 3143 CARTONS PH ARMACEUTICALS AS UNDER TELMIS ARTAN TABLETS 20MG 30 S NDC C ODE:68462019930 FDA PRODUCT C ODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO. :090032 THERAPEUTICE USE: IN DICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC INDOMETHACIN C APS 25MG 100 S NDC CODE:68462 040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 30 04.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLAM ATORY ROPINIROLE TABS 0.5MG 1 00 S NDC CODE:68462025401 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM OXCARBAZEPINE TABLETS 300MG 100 S NDC CODE:684620 13801 FDA PRODUCT CODE NO. :-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT LITHIUM CA RBONATE CAPS 150MG 100 S NDC CODE:68462022001 FDA PRODUC T CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 79 -139 THERAPEUTI CE USE:-ANTIMANIC AGENT LA MOTRIGINE TABLETS FOR OS(CD)25 MG100 S NDC CODE:68462022901 FDA PRODUCT CODE NO.:-61 M C A 38 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-79 # 099 T HERAPEUTICE USE:-ANTICONVULSAN T 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200379 1 DT. 22.10.2021 SBILL NO DT 5495765 23.10.20 21 TOTAL GR.WT.:10911.61KGS TOTAL NT.WT.:8849.48KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10911
KG
41
PKG
0
USD
MAEU608910666
2022-03-09
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 19 PALLETS CONSISTING OF1600 C ARTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500 MG 500 S NDC CODE: 6846201 9005 FDA PRODUCT CODE NO.: -62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OM EPRAZOLE DR CAPSULES 40MG 30 S NDC CODE:68462039730 FD A PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX D ISEASE MUPIROCIN CREAM 2% 15GM NDC CODE: 68462056417 FDA PRODUCT CODE NO.: 61G CJ82 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 201587 THE RAPEUTICE USE: - TOPICAL ANT I-BACTERIAL MUPIROCIN CREAM 2% 30GM NDC CODE: 684620 56435 FDA PRODUCT CODE NO. : 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 20158 7 THERAPEUTICE USE: - TOPI CAL ANTI-BACTERIAL 02 DATA L OGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2225200 5541 DT. 05.02.2022 F2225200 5539 DT. 04.02.2022 TOTAL NE T WT.:3982.30KGS SBILL NO DT. 8023698 06-F EB-2022 8023636 06-FEB- 2022 NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4880
KG
19
PKG
0
USD
MAEU216273001
2022-03-02
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 CONTAINER 19 PALLETS 19 P ALLETS CONSISTING OF 947 CARTO NS 1X40 PART OF FCL REEFER PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 100 S NDC CODE:6846201900 1 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 AN DA NO.:-78-250 THERAPEUTI CE USE:-ANTI-INFLAMMATORY , ANALGESIC NA PROXEN TABLETS 500MG 500 S NDC CODE:68462019005 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY, AN ALGESIC PRAMIPEXOLE TABS 1MG 90 S NDC CODE:6 8462033390 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 T HERAPEUTICE USE: USED IN PARKINSON#S DISEASE GABAPENTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT A GENT 01 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222520053 54 DT. 28.01.2022 F2225200535 6 DT. 28.01.2022 SBILL NOS DT. 7836397 29-JAN-20 22 7835871 29-JAN-2022 T OTAL GR.WT.: 6,067.50 KGS TOT AL NT.WT: 5,359.75 KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6067
KG
19
PKG
0
USD
MAEU217679575
2022-05-04
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 4 PALLETS 97 CARTONS PHAR MACEUTICALS AS UNDER LIDOCA INE OINTMENT JAR 5% 50GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO. :206498 THERAPEUTICE USE: -US ED TO TEMPORARILY RELIEVE PA IN AND ITCHING ASSOCIATED WIT H SKIN COMMERCIAL & CUSTOM INVOICE NO. F22252006369 DT. 31.03.2022 NET WT: 908.17 K GS 00 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1065
KG
4
PKG
0
USD
MAEU914132405
2022-05-04
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 42 PALLETS 2220 CARTONS P HARMACEUTICALS AS UNDER LIDOC AINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRO DUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 AND A NO.:206498 THERAPEUTICE USE : -USED TO TEMPORARILY RELIEV E PAIN AND ITCHING ASSOCIATE D WITH SKIN LIDOCAINE OINTM ENT TUBE 5% 35.44GM NDC CODE: 68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:2064 98 THERAPEUTICE USE: -USED T O TEMPORARILY RELIEVE PAIN AN D ITCHING ASSOCIATED WITH SKI N CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:684620297 92 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.4 0.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. THEOPHYLLINE ER TABS 3 00MG 100 S NDC CODE:684620721 01 63 B C B 30 3004.90.92.85 212184 TO RELEASE TABLETS A RE INDICATED FOR THE TREATME NT OF THE SYMPTOMS AND REVER SIBLE AIRFLOW OBSTRUCTION ASS OCIATED WITH CHRONIC ASTHMA A ND OTHER CHRONIC LUNG DISEASE S, E.G., EMPHYSEMA AND CHRON IC BRONCHITIS LITHIUM CARBO NATE CAPS 300MG 1000 S NDC CO DE:68462022110 FDA PRODUCT CO DE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.: - 79 -139 THERAPEUTICE USE:- ANTIMANIC AGENT VERAPAMIL H CL ER TABS 120MG 100S NDC COD E:68462029201 FDA PRODUCT COD E NO.: 62 O C B 13 H. T. S N O.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - A NGINA LITHIUM CARBONATE ER TABS 450MG 100 S NDC CODE:684 62022401 FDA PRODUCT CODE NO. : 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-616 THERAPEUTICE USE: - INDICAT ED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER . BIPOLAR DISORDER, MANIC (D SM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, I N THE OLDER DSM-II TERMINOLOG Y. ALSO INDICATED AS A MAINT ENANCE TREATMENT FOR INDIVIDU ALS WITH A DIAGNOSIS OF BIPO LAR DISORDER. MAINTENANCE THE RAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISH ES THE INTENSITY OF THOSE EPI SODES WHICH MAY OCCUR. VER APAMIL HCL ER TABS 240MG 500 S NDC CODE:68462026005 FDA PR ODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 A NDA NO.:-78-906 THERAPEUTICE USE:-ANGINA OLMESARTAN MED OXOMIL TABLETS 20MG NDC CODE: 68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3 004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - TREATMEN T OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE A GENTS, TO LOWER BLOOD PRESSUR E VERAPAMIL HCL ER TABS 120 MG 100S NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-700 THERAP EUTICE USE: - ANGINA LITHI UM CARBONATE CAPS 300MG 100 S NDC CODE:68462022101 FDA PRO DUCT CODE NO.:-61 N C E 37 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 79 -139 THERAPEUTICE USE:-ANTIMANIC AGENT ZOLM ITRIPTAN TABLETS 5MG 3 S NDC CODE:68462049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO .: 201779 THERAPEUTICE USE: - ANALGESIC/ HUMAN - RX/SINGL E INGREDIENT / PROMPT RELEAS E TABLETS / ZOLMITRIPTAN (ANA LGESIC) COMMERCIAL & CUSTOM I NVOICE NO. F22252006340 DT. 3 1.03.2022 F22252006350 DT. 31 .03.2022 F22252006367 DT. 31. 03.2022 F22252006372 DT. 31.0 3.2022 F22252006377 DT. 31.03 .2022 F22252006380 DT. 31.03. 2022 S/BILL NO: 9496822 DT: 05-APR-22 S/BILL NO: 9496828 DT: 05-APR-22 S/BILL NO: 94 97545 DT: 05-APR-22 S/BILL NO : 9496646 DT: 05-APR-22 S/BI LL NO: 9496820 DT: 05-APR-22 S/BILL NO: 9496826 DT: 05-AP R-22 NET WT: 9,414.21 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11501
KG
42
PKG
0
USD
MAEU216329742
2022-03-02
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER 44 PALLET S CONSISTING OF2477 CARTONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004. 49.00.50 ANDA NO.:206498 T HERAPEUTICE USE: -USED TO TE MPORARILY RELIEVE PAIN AND I TCHING ASSOCIATED WITH SKIN OMEPRAZOLE DR CAPSULES 40M G 90 S NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAP EUTICE USE: - TREATMENT OF T REAT GASTROESOPHAGEAL REFLUX DISEASE VERAPAMIL HCL E R TABS 240MG 500 S NDC CODE: 68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-78-906 THERAPEUTICE USE :-ANGINA TOPIRAMATE TABLET S 50MG 1000 S NDC CODE:68462 015310 FDA PRODUCT CODE NO .:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-AN TICONVULSANT ROPINIROLE TABS 0.25MG 100 S NDC CODE:684 62025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:- TREATMENT OF PARKINSONISM GABAPENTIN TABLETS 800MG 500 S NDC CODE: 68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULS ANT AGENT NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES CUS TOM INVOICE NO.& F22252005384 DT. 29.01.2022 F22252005388 DT. 29.01.2022 F22252005397 DT. 29.01.2022 F22252005376 DT. 29.01.2022 F22252005392 DT. 29.01.2022 TOTAL NET W T.:10695.27KGS SB NO & DATE ON BL 7911492 01-FEB-2022 7911445 01-FEB-2022 7911424 01-FEB-2022 7911407 01-FEB -2022 7910960 01-FEB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12093
KG
44
PKG
0
USD
MAEU218682322
2022-06-22
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 1996 CART ONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT JAR 5% 5 0GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:206498 THERAPEUTICE USE: -USED TO TEMPORARILY RE LIEVE PAIN AND ITCHING ASSOC IATED WITH SKIN HEATHER NOR ETHINDRONE 0.35MG 84 NDC CODE :68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO .: 3006.60.00.00 ANDA NO.:90 -454 THERAPEUTICE USE: PREVE NTION OF PREGNANCY. NORETHI NDRONE 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. FELODIPINE ER TABS 2.5MG 100 S NDC CODE: 68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - TREATME NT OF HYPERTENSION TOPIRAM ATE TABLETS 100MG 1000 S NDC CODE:68462010910 FDA PRODUCT CODE NO.:61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F22352000 718 DT. 26.05.2022 F223520007 19 DT. 26.05.2022 F2235200072 0 DT. 26.05.2022 NET WT: 5 ,794.78 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 1684332 DT 26-MAY-2022 S/BIL L NO: 1684334 DT 26-MAY-2022 S/BILL NO: 1684337 DT 26-MAY-2 022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7497
KG
40
PKG
0
USD
MAEU217387974
2022-04-27
613200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 3 PALLETS 54 CARTONS PHARMACEUTICAL S AS UNDER APREPITANT CAPSU LES 80MG 2UOU NDC CODE:684620 58458 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 T HERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND V OMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). TH IS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EMETIC/NAUS EANT / HUMAN - RX/SINGLE ING REDIENT / DELAYED RELEASE TAB LETS / APREPITANT NITROGLY CERIN SUBLING TABS 0.6MG 100 S NDC CODE:68462064001 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCI AL & CUSTOM INVOICE NO. F2228 7002071 DT. 30.03.2022 S/BILL NO: 4004810 DT: 31.03.2022 NET WT. 12.37 KGS 03 DATA LO GGERS NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
350
KG
3
PKG
0
USD
MAEU913326482
2021-12-02
613200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 5 P ALLETS CONSISTING OF 408 CARTO NS PHARMACEUTICALS AS UNDER APREPITANT CAPSULES 80MG 6UD NDC CODE:68462058476 FDA PROD UCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 AND A NO.:207777 THERAPEUTICE US E:APREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSE A AND VOMITING AFTER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAY ED RELEASE TABLETS / APREPIT ANT APREPITANT CAPSULES 125MG 6UD NDC CODE:68462058576 NDC NO.:68462058576 FD A PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 THERAPEUTICE USE:APRE PITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUS ED BY CANCER DRUG TREATMEN T (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMIT ING AFTER SURGERY. A-EMETI C/NAUSEANT / HUMAN - RX/SI NGLE INGREDIENT / DELAYED RELEASE TABLETS / APRE PITANT ROSUVASTATIN TABLET S 10MG 90 S NDC CODE:68462026 290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 079172 THE RAPEUTICE USE: - TO TREAT HIG H CHOLESTEROL AND RELATED CON DITIONS, AND TO PREVENT CARD IOVASCULAR DISEASE 05 DATA LO GGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES CO MMERCIAL & CUSTOM INVOICE NO. F22287001239 DT. 28.10.2021 F22287001277 DT. 01.11.2021 TOTAL GR.WT.:814.99KGS TOTAL NT.WT.:116.20KGS SBILL NO. DT. 4017276 28.10.2021 4017594 01.11.2021<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
815
KG
5
PKG
0
USD
MAEU218071767
2022-05-19
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 2 PALLETS 63 CART ONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 100 S NDC CODE:68462063 901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.: 206391 THE RAPEUTICE USE: MEDICATION USE D FOR HEART FAILURE, HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTE NOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOIC E NO. F22387000104 DT. 22.04. 2022 S/BILL NO: 4005813 DT: 23.04.2022 NET WT: 33.11 KG S 02 DATA LOGGERS NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE N UMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
395
KG
2
PKG
0
USD
KWLD70330048244
2021-05-05
662800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLINODUCT CODE NO. 66 S C A 28 H. T. S NO. 3004 .90.9020 ANDA NO.206391 THERAPEUTI . .<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
878
KG
4
PKG
0
USD
MAEU217679666
2022-05-04
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 10 PALLETS 288 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TABS 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART APREPI TANT CAPSULES 40MG 1UD NDC CO DE:68462058340 FDA PRODUCT CO DE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT NITROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE:684620639 45 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.9 0.9020 ANDA NO.:206391 THERA PEUTIC USE: MEDICATION USED F OR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PRE VENT CHEST PAIN FROM NOT ENOU GH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING TABS 0. 4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90. 9020 ANDA NO.:206391 THERAPE UTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PR ESSURE,AND TO TREAT AND PREVE NT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART C OMMERCIAL & CUSTOM INVOICE NO. F22287002081 DT. 31.03.2022 F22287002106 DT. 31.03.2022 F22287002112 DT. 31.03.2022 F 22287002120 DT. 31.03.2022 S/ BILL NO:4004991 DT:04/04/2022 S/BILL NO: 4004990 DT:04/04/2 022 S/BILL NO:4004994 DT:04/0 4/2022 S/BILL NO: 4004995 DT: 04/04/2022 NET WT: 128.89 KG S 10 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2071
KG
10
PKG
0
USD
MAEU218465385
2022-06-08
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 8 PALLETS 244 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TABS 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLY CERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART F AILURE,HIGH BLOOD PRESSURE,AN D TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FL OW TO THE HEART NITROGLYCE RIN SUBLING TABS 0.4MG 4X25 N DC CODE:68462063945 FDA PRODU CT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F22387000 165 DT. 30.04.2022 F223870001 69 DT. 30.04.2022 F2238700020 7 DT. 11.05.2022 S/BILL NO:40 06762 DT: 11.05.2022 S/BILL N O: 4006764 DT: 11.05.2022 S/B ILL NO: 4006766 DT: 11.05.2022 NET WT: 130.00 KGS 08 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1984
KG
8
PKG
0
USD
MAEU216355708
2022-03-02
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 07 PALLETS CONSISTING OF 197 C ARTONS PHARMACEUTICALS AS UN DER NITROGLYCERIN SUBLING TABS 0.6MG 100 S NDC CODE:68 462064001 FDA PRODUCT CODE N O.: 66 S C A 28 H. T. S NO .: 3004.90.9020 ANDA NO.:2 06391 THERAPEUTIC USE: MED ICATION USED FOR HEART FAILU RE,HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLO W TO THE HEART NITROGLYCER IN SUBLING TABS 0.4MG 100 S NDC CODE:68462063901 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEU TICE USE: MEDICATION USED FO R HEART FAILURE, HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTE NOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TA BS 0.4MG 4X25 NDC CODE:68462 063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:2063 91 THERAPEUTIC USE: MEDICA TION USED FOR HEART FAILURE, HIGH BLOOD PRESSURE,AND TO T REAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW T O THE HEART 07 DATA LOGGER S COMMERCIAL & CUSTOM INVOICE NO. F22287001739 DT. 31.01.2022 F22287001740 DT. 31.01.2022 F22287001757 DT. 31.01.2022 SBILL NO. DT. 4001696 03. 02.2022 4001685 03.02.2 022 4001684 03.02.2022 TOTAL NET WT. 104.02KG S<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1285
KG
7
PKG
0
USD
MAEU214106776
2021-11-18
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REEFER PART OF FCL CONTAI NER 9 PALLETS CONSISTING OF 3 48 CARTONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 100 S NDC CODE:684 62063901 FDA PRODUCT CODE NO. : 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: MEDICATIO N USED FOR HEART FAILURE, HIG H BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING T ABS 0.4MG 4X25 NDC CODE:68462 063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 30 04.90.9020 ANDA NO.:206391 T HERAPEUTIC USE: MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TABS 0.3MG 100 S NDC CODE:68462063 801 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.:206391 THER APEUTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PR EVENT CHEST PAIN FROM NOT ENO UGH BLOOD FLOW TO THE HEART APREPITANT CAPSULES 40MG 5UD NDC CODE:68462058385 FDA PROD UCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 AND A NO.:207777 THERAPEUTICE US E:APREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSE A AND VOMITING AFTER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAY ED RELEASE TABLETS / APREPIT ANT 09 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22287001201 DT. 21.10.2021 F 22287001202 DT. 21.10.2021 TO TAL GR.WT.: 1659.31KGS TOTAL NT.WT: 113.27KGS SBILL NOS DT 4016836 21.1 0.2021 4016835 21.10.2 021 NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. AVENUE L EOPOLD-ROBERT 37 LA CHAUX-D E-FONDS - 2300 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1659
KG
9
PKG
0
USD
KWLD70330062935
2021-11-19
621000 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN 2187 CARTONS PACKED I NDER OMEPRAZOLE DR CAPSULES 40MG 1000S NDC C ODE68462039710 FDA PRODUCT CODE NO.62KCF10<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10419
KG
2187
CTN
0
USD
MAEU914178600
2022-05-11
621000 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 2916 CARTONS P HARMACEUTICALS AS UNDER OME PRAZOLE DR CAPSULES 20MG 90 S NDC CODE:68462039690 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE VER APAMIL HCL ER TABS 180MG 500S NDC CODE:68462029305 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 90-700 THERAPEUTICE U SE: - ANGINA VERAPAMIL HCL ER TABS 240MG 100 S NDC CODE :68462026001 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 8-906 THERAPEUTICE USE:-ANGI NA PRAMIPEXOLE TABS 0.5MG 9 0 S NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 1 5 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 1MG 90 S NDC CODE:68462033390 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEU TICE USE: USED IN PARKINSON#S DISEASE NAPROXEN TABLETS 5 00MG 30 S NDC CODE:6846201903 0 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC OXCARBAZEPIN E TABLETS 600MG 100 S NDC COD E:68462013901 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ROPINIRO LE TABS 3MG 100 S NDC CODE:68 462025701 FDA PRODUCT CODE NO .:-62 J C A 17 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 90-13 5 THERAPEUTICE USE:-TREATMENT OF PARKINSONISM NORETHINDR ONE 0.35MG 84 NDC CODE:684620 30529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 300 6.60.00.00 ANDA NO.:91-209 T HERAPEUTICE USE: PREVENTION O F PREGNANCY. COMMERCIAL & C USTOM INVOICE NO. F2235200007 4 DT. 09.04.2022 F22352000094 DT. 12.04.2022 S/BILL NO: 96 60311 DT. 12.04.2022 S/BILL N O: 9660309 DT. 12.04.2022 NET WT. 7,876.88 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9576
KG
40
PKG
0
USD
KWLD70330060950
2021-11-15
621000 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN 3910 CARTONS PACKED I UNDER OMEPRAZOLE DR CAPSULES 40MG 100S NDC C ODE68462039701 FDA PRODUCT CODE NO. 62KCF10<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9557
KG
3910
CTN
0
USD
MAEU218335981
2022-06-08
621000 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 39 PALLETS 1638 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PR ODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE LAMO TRIGINE TABLETS FOR OS(CD)25MG 100 S NDC CODE:68462022901 F DA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-79 # 099 THERA PEUTICE USE:- ANTICONVULSANT ONDANSETRON TABLETS 8MG 30 S NDC CODE:68462010630 FDA P RODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 A NDA NO.:- 77-535 THERAPEUTICE USE:-ANTI EMETIC NAPROXEN TABLETS 500MG 500 S NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC T RANDOLAPRIL-VERAPAMIL TAB 2/18 0MG 100 S NDC CODE:6846202950 1 FDA PRODUCT CODE NO.:-62 O D A 11 H. T. S NO.: 3004.90 .92.20 ANDA NO.:-79-135 THER APEUTICE USE:-TREATMENT OF H YPERTENSION NORGEST/EE 0.18 ,0.215,0.25/0.035MG 84 NDC CO DE:68462056529 FDA PRODUCT CO DE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTICE USE: - O RAL CONTRACEPTIVES 08 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F223520003 95 DT. 30.04.2022 F2235200050 7 DT. 10.05.2022 S/BILL NO: 1 282151 DT: 10/05/2022 S/BILL NO: 1321682 DT:11/05/2022 NE T WT: 6247.98 KGS NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7301
KG
39
PKG
0
USD
KWLD70330071373
2022-03-31
652600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN 1994 CARTONS 1994 CAR UNDER NORETHINDRONE 0.35MG 84 NDC CODE68462 030529 FDA PRODUCT CODE NO. 65 J C A 26 H. T<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7249
KG
1994
PKG
0
USD
KWLD70330067426
2022-01-26
652600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN 1894 CARTONS PACKED I R NORETHINDRONE 0.35MG 84 NDC CODE6846203052 9 FDA PRODUCT CODE NO. 65 J C A 26 H. T. S N<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7326
KG
1894
PKG
0
USD
KWLD70330071160
2022-03-31
652600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 529 FDA PRODUCT CODE NO. 65 J C A 26 H. T. S NO. 3006.60.00.00 ANDA NO.91-209 THERAPEUT<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5098
KG
918
CTN
0
USD
KWLD70330071558
2022-03-31
652600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 529 FDA PRODUCT CODE NO. 65 J C A 26 H. T. S NO. 3006.60.00.00 ANDA NO.91-209 THERAPEUT<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1165
KG
304
CTN
0
USD
MAEU218637299
2022-06-22
615100 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 34 PALLETS 1730 CARTONS PHARMACEUTICALS AS UNDER LE VOCETIRIZINE DIHY TABS 5MG 90 S NDC CODE:68462034690 FDA P RODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:90385 THERAPEUTICE U SE: TREATMENT OF CHRONIC IDI OPATHIC URTICARIA OMEPRAZOL E DR CAPSULES 20MG 1000 S NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S N O.: 3004.90.9160 ANDA NO.: 9 1672 THERAPEUTICE USE: - TRE ATMENT OF TREAT GASTROESOPHAG EAL REFLUX DISEASE COMMERC IAL & CUSTOM INVOICE NO. F223 52000649 DT. 19.05.2022 S/BIL L NO: 1527298 DT 20-MAY-2022 NET WT: 5870.6 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6948
KG
34
PKG
0
USD
MAEU914140069
2022-05-04
615100 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 41 PALLETS 3561 CARTONS P HARMACEUTICALS AS UNDER ONDAN SETRON TABLETS 4MG 30 S NDC C ODE:68462010530 FDA PRODUCT C ODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO. :- 77-535 THERAPEUTICE USE:-A NTI EMETIC LEVOCETIRIZINE DIHY TABS 5MG 90 S NDC CODE:6 8462034690 FDA PRODUCT CODE N O.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:9038 5 THERAPEUTICE USE: TREATMEN T OF CHRONIC IDIOPATHIC URTIC ARIA OXCARBAZEPINE TABLETS 600MG 100 S NDC CODE:68462013 901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004. 90.92.30 ANDA NO.:-77-802 TH ERAPEUTICE USE:-ANTI CONVULSA NT AGENT PRAVASTATIN SODIUM TAB 40MG 500 S NDC CODE:6846 2019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDA EMIC OLMESARTAN MEDOXOMIL T ABLETS 40MG 90 S NDC CODE:684 62043890 FDA PRODUCT CODE NO. : 62 CCA 68 H. T. S NO.: 30 04.90.9220 ANDA NO.: 203281 TREATMENT OF HYPERTENSION, AL ONE OR WITH OTHER ANTIHYPERT ENSIVE AGENTS, TO LOWER BLOOD PRESSURE ZOLMITRIPTAN ODT 5MG 3 S NDC CODE:68462050033 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.9 2.28 ANDA NO.: 202560 THERAP EUTICE USE: - ANALGESIC/ HUMA N - RX/SINGLE INGREDIENT / P ROMPT RELEASE TABLETS / ZOLM ITRIPTAN (ANALGESIC) COMMERCI AL & CUSTOM INVOICE NO. F2225 2006298 DT. 31.03.2022 S/BILL NO: 9462490 DT:04-APR-22 NE T WT: 6,837.35 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8638
KG
41
PKG
0
USD
MAEU214106806
2021-11-18
620900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REEFER FCL CONTAINER 48 PALLETS CONSISTING OF 3532 CAR TONS PHARMACEUTICALS AS UNDER TELMISARTAN TABLETS 40MG 30 S NDC CODE:68462020030 FDA P RODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:090032 THERAPEUTICE USE: INDICATED FOR THE TREAT MENT OF HYPERTENSION, TO LOWE R BLOOD PRESSURE OMEPRAZOLE DR CAPSULES 40MG 30 S NDC COD E:68462039730 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE PRAMIPEXOLE T ABS 0.125MG 90 S NDC CODE:684 62033090 FDA PRODUCT CODE NO. : 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-78 1 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE CALCIPOTR IENE OINTMENT 0.005% 60GM NDC CODE:68462031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CA LCIPOTRIENE IS A FORM OF VITA MIN D. IT WORKS BY SLOWING DO WN THE GROWTH OF SKIN CELLS. CLOTRIMAZOLE CREAM 1% 30GM N DC CODE:68462018135 FDA PRODU CT CODE NO :61 W C J 04 H. T . S NO.: 3004.90.92.45 ANDA NO.: 90-219 THERAPEUTICE USE: TREATMENT OF CANDIDIASIS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22252003 759 DT. 20.10.2021 F222520037 60 DT. 20.10.2021 SBILL NO. D T. 5472027 22-OCT-2021 5473 740 22-OCT-2021 TOTAL GR.WT. : 12055.14KGS TOTAL NT.WT: 95 10.15KGS FREIGHT PREPAID<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12055
KG
48
PKG
0
USD
KWLD70330071559
2022-03-31
652600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 529 FDA PRODUCT CODE NO. 65 J C A 26 H. T. S NO. 3006.60.00.00 ANDA NO.91-209 THERAPEUT<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10083
KG
2309
CTN
0
USD
KWLD70330068854
2022-02-21
652600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN 1992 CARTONS 1992 CAR UNDER NORETHINDRONE 0.35MG 84 NDC CODE68462 030529 FDA PRODUCT CODE NO. 65 J C A 26 H. T<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6437
KG
1992
PKG
0
USD
MAEU914178639
2022-05-11
652600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 52 PALLETS 2258 CART ONS PHARMACEUTICALS AS UNDER NORETHINDRONE 0.35MG 84 ND C CODE:68462030529 FDA PRODUC T CODE NO.: 65 J C A 26 H. T . S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. N ORETHINDRONE ACE/EE TABS 1/0.0 2MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206969 THERAPEUT ICE USE: - SECONDARY AMENORR HEA,ENDOMETRIOS IS AND ABNORM AL UTERINE BLEEDING OMEPRA ZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PROD UCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE INDOME THACIN CAPS 50MG 100 S NDC CO DE:68462030201 FDA PRODUCT CO DE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.: 91-276 THERAPEUTICE USE: ANT I-INFLAMATORY INDOMETHACIN CAPS 50MG 500 S NDC CODE:6846 2030205 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3 004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLA MATORY INDOMETHACIN CAPS 25 MG 100 S NDC CODE:68462040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90. 92.40 ANDA NO.:91-276 THERAP EUTICE USE: ANTI-INFLAMATORY COMMERCIAL & CUSTOM INVOICE NO. F22352000129 DT. 14.04.2 022 F22352000132 DT. 14.04.20 22 F22352000134 DT. 14.04.202 2 S/BILL NO: 9731836 DT:16.04 .2022 S/BILL NO:9733093 DT: 1 6.04.2022 S/BILL NO: 9733164 DT: 16.04.2022 NET WT: 6,52 5.58 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 074 30 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8269
KG
52
PKG
0
USD
MAEU216328357
2022-03-02
652600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 23 PACKAGES CONSISTING OF 1084 C ARTONS PHARMACEUTICALS AS U NDER NORETHINDRONE 0.35MG 84 NDC CODE: 68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.6 0.00.00 ANDA NO.:91-209 TH ERAPEUTICE USE: PREVENTION O F PREGNANCY. DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE: 68462072029 FDA PRODUCT COD E NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA N O.: 204296 THERAPEUTICE US E: - ORAL CONTRACEPTIVE 01 DATA LOGGERS SET TEMP ERATURE : +20 DEGREES SB ILL NO. DT. 7835434 29-JA N-2022 COMMERCIAL & CUSTOM IN VOICE NO. F22252005352 DT. 2 8.01.2022 TOTAL NET.WT: 2 569.90KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3547
KG
23
PKG
0
USD
MAEU218682321
2022-06-22
652600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 33 PALLETS 1642 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE 0.35MG 84 NDC CODE: 68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO. : 3006.60.00.00 ANDA NO.:91- 209 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. NORETHIN DRONE 0.35MG 84 NDC CODE:6846 2030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3 006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. ASHLYNA LEVO /EE 0.15/0.03MG 182 NDC CODE: 68462064693 FDA PRODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 2031 63 THERAPEUTICE USE: - INDIC ATED FOR USE BY WOMEN TO PREV ENT PREGNANCY PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462 060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO NIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE DI LTIAZEM HCL ER CAPS 12HR 60MG 100 S NDC CODE:68462085001 6 2 O C B 24 3004.49.00.10 212 317 FOR THE TREATMENT OF HYP ERTENSION. CARVEDILOL TABS 12.5MG 100 S NDC CODE:6846201 6401 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST COMME RCIAL & CUSTOM INVOICE NO. F2 2352000708 DT. 25.05.2022 F22 352000710 DT. 25.05.2022 F223 87000238 DT. 20.05.2022 F2238 7000240 DT. 20.05.2022 F22387 000241 DT. 20.05.2022 S/BILL NO: 1680051 DT: 26/05/2022 S /BILL NO: 1680054 DT:26/05/20 22 S/BILL NO: 4007229 DT:20/ 05/2022 S/BILL NO: 4007220 D T:20/05/2022 S/BILL NO: 40072 34 DT:20/05/2022 NET WT. 3, 859.20 KGS 07 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK PHARMACEUTICALS LTD. PLOT NO 2, ISEZ, PHASE II,PHA RMA ZONE PITHAMPUR, DIST DHAR , MADHYA PRADESH INDIA GST NO . : 23AAACG2207L2ZZ<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5639
KG
33
PKG
0
USD
KWLD70330058975
2021-09-30
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10160
KG
2479
CTN
0
USD
KWLD70330072070
2022-04-05
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN 1387 CARTONS 1387 CAR UNDER MUPIROCIN OINTMENT 2 22GM NDC CODE68 462018022 FDA PRODUCT CODE NO. 61 G J J 81 H<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7749
KG
1387
PKG
0
USD
KWLD70330064253
2021-11-29
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN 1255 CARTONS PACKED I S UNDER MUPIROCIN OINTMENT 2 22GM NDC CODE6 8462018022 FDA PRODUCT CODE NO. 61 G J J 81<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10815
KG
1255
CTN
0
USD
KWLD70330072579
2022-04-19
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
189
KG
64
PKG
0
USD
KWLD70330072580
2022-04-19
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9622
KG
4500
PKG
0
USD
KWLD70330072568
2022-04-08
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11217
KG
4448
PKG
0
USD
KWLD70330072577
2022-04-08
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6285
KG
1013
PKG
0
USD
KWLD70330072567
2022-04-08
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
968
KG
320
PKG
0
USD
KWLD70330072576
2022-04-08
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7022
KG
2319
PKG
0
USD
KWLD70330072555
2022-04-09
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1853
KG
614
PKG
0
USD
KWLD70330072556
2022-04-09
618100 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T . S NO. 3004.90.92.45 ANDA NO. 90-480 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1055
KG
136
PKG
0
USD
MAEU216470570
2022-03-09
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 26 PALLETS CONSISTING 2583 C ARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TABLETS 10MG 90 S NDC CODE: 68462 026290 FDA PRODUCT CODE NO .:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISE ASE AZELAIC ACID GEL 15% 5 0GM NDC CODE: 68462062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 204637 INDICATED FOR TOPICAL TREATM ENT OF THE INFLAMMATORY PAPU LES AND PUSTULES OF MILD TO MODERATE ROSACEA 26 DATA L OGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222520 05540 DT. 05.02.2022 F2225 2005538 DT. 04.02.2022 SBILL NO. DT. 8023741 06- FEB-2022 8023564 06-FEB-20 22 TOTAL NET WT.4483.56KGS GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE NUMA- DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5756
KG
26
PKG
0
USD
MAEU218958276
2022-07-01
611600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 11 PALLETS IN 897 CARTONS RO SUVASTATIN TABLETS 10MG 1000 S NDC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TABLETS 10MG 9 0 S NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE ROSUVASTATIN TAB LETS 10MG 90 S NDC CODE:68462 026290 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT C ARDIOVASCULAR DISEASE 11 DATA LOGGERS HUMIDITY:65% COMMER CIAL & CUSTOM INVOICE NO. F22 352000805 DT. 30.05.2022 F223 52000846 DT. 31.05.2022 NET W T.: 1473.62 KGS NOTIFY PART Y:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA -DROZ 2 NEUCHATEL - 2000 SWI TZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1853
KG
11
PKG
0
USD
MAEU216791108
2022-03-24
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 267 CARTONS PACKED I N 6 PALLETS PHARMACEUTICALS A S UNDER ROSUVASTATIN TABLETS 40MG 500 S NDC CODE:684620264 05 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TABLETS 20MG 1000 S NDC CODE:68462026 310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 79172 TH ERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CARDIOV ASCULAR DISEASE NET WT: 1,3 74.96 KGS GROSS WT: 1,541.19 KGS 06 DATA LOGGERS SET TEMPERATURE : +20 DEGREES C ONTAINER NO. TTNU8759835 CO MMERCIAL & CUSTOM INVOICE NO. F22252005768 DT. 23.02.2022 F22252005786 DT. 23.02.2022 SB NO.: 8492798 DT.: 25/02/22 SB NO,: 8492826 DT.: 25/02/2 2<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1541
KG
6
PKG
0
USD
MAEU218800472
2022-07-01
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 4 PALLETS 357 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TABLETS 10MG 90 S NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22352000775 DT. 29.0 5.2022 NET WT: 496.223 KGS 0 4 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA -DROZ 2 NEUCHATEL - 2000 SWI TZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
646
KG
4
PKG
0
USD
MAEU219009636
2022-07-07
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 19 PALLETS 1637 CART ONS PHARMACEUTICALS AS UNDE R ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PR ODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 79172 THERAPEUTICE U SE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE. ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22352000973 DT. 08.06.2022 NET WT. 2,057 .62 KGS 19 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND S/B ILL NO: 2009620 DT: 09-JUN-22<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2709
KG
19
PKG
0
USD
MAEU214152367
2021-11-18
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 PART OF FCL REEFER 8 (EI GHT)PALLETS CONSISTING OF 1060 CARTONS PHARMACEUTICALS AS U NDER ROSUVASTATIN TABLETS 40M G 30 S NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTER OL AND RELATED CONDITIONS , AND TO PREVENT CAR DIOVASCULAR DISEASE ROSUVASTATIN TABLETS 5MG 90 S NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIO NS, AND TO PREVENT C ARDIOVASCULAR DISEASE 08 DATA LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES COMME RCIAL & CUSTOM INVOIC E NO. F22287001173 DT. 18.10.2021 S BILL NO. 4016671 DT. 18/10/20 21 TOTAL GR.WT.: 2090.95KGS TOTAL NT.WT.:391.78KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2091
KG
8
PKG
0
USD
MAEU216791392
2022-03-24
652700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 1994 CARTONS PACKED IN40 PALLETS PHARMACEUTICALS AS UNDER NORGEST/EE 0.25/0.03 5MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200538 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE:68462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00 00 ANDA NO.: 204296 THERAPEUTIC E USE: - ORAL CONTRACEPTIVE DROSPIRENONE/EE 3.0/0.03MG 84 NDC CODE:68462073329 FDA PRO DUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY NET WT: 4,361.42 KGS GROSS WT: 6,062.05 KGS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES CONTAI NER NO. MNBU9139449 COMMERC IAL & CUSTOM INVOICE NO. F222 52005773 DT. 23.02.2022 SB NO.: 8463761 DT.: 24/02/22<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6062
KG
40
PKG
0
USD
KWLD70330058830
2021-09-30
652700 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN CODE68462056529 FDA PRODUCT CODE NO. 65 J D A 27 H. T. S NO. 3006.60.00.00 ANDA NO. 2<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7570
KG
2000
CTN
0
USD
KWLD70330072099
2022-04-05
652700 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 030929 FDA PRODUCT CODE NO. 65 J D A 27 H. T . S NO. 3006.60.00.00 ANDA NO. 200538 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2285
KG
338
PKG
0
USD
MAEU218335970
2022-06-08
652700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 2000 CARTONS P HARMACEUTICALS AS UNDER NOR GEST/EE 0.18,0.215,0.25/0.035M G 84 NDC CODE:68462056529 FD A PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200494 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S COMMERCIAL & CUSTOM INVOI CE NO. F22352000512 DT. 11.05 .2022 S/BILL NO:1324415 DT 11 -MAY-2022 NET WT: 5,880.00 KGS 02 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7458
KG
40
PKG
0
USD
KWLD70330072101
2022-04-05
652700 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 030929 FDA PRODUCT CODE NO. 65 J D A 27 H. T . S NO. 3006.60.00.00 ANDA NO. 200538 THERA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6678
KG
960
PKG
0
USD
KWLD70330058984
2021-09-30
652700 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAINPHARMACEUTICALS AS UND 30929 FDA PRODUCT CODE NO. 65 J D A 27 H. T. S NO. 3006.60.00.00 ANDA NO. 200538 THERAP<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7160
KG
1966
CTN
0
USD
KWLD70330063091
2021-11-19
652700 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN 1719 CARTONS PACKED I S UNDER NORGEST/EE 0.25/0.035MG 84 NDC CODE6 8462030929 FDA PRODUCT CODE NO. 65 J D A 27<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7504
KG
1719
CTN
0
USD
MAEU216796759
2022-03-24
652700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 1966 CARTONS PACKED IN 40 PALLETS PHARMACEUTICALS AS UNDER NORGEST/EE 0.18,0.2 15,0.25/0.035MG 84 NDC CODE:6 8462056529 FDA PRODUCT CODE N O.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200 494 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NORGEST/EE 0. 25/0.035MG 84 NDC CODE:6846 2030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CO NTRACEPTIVES NORGEST/EE 0.25/ 0.035MG 84 NDC CODE:684620309 29 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.6 0.00.00 ANDA NO.: 200538 THE RAPEUTICE USE: - ORAL CONTRAC EPTIVES NET WT.: 5898.00 KGS GROSS WT.: 7521.61 KGS COMME RCIAL & CUSTOM INVOICE NO. F2 2252005658 DT. 15.02.2022 F22 252005745 DT. 21.02.2022 F222 52005746 DT. 21.02.2022 SB NO.: 8265334 DT.: 16/02/22 SB NO.: 8418073 DT.: 22/02/22 S B NO.: 8422454 DT.: 22/02/22 03 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES CONTAINE R NO.: MNBU0513120 MANUFACT URE D FOR GLENMARK PHARMACE UTICAL S INC., USA 301, ISLA ND RD MAHWAH<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7522
KG
10
PKG
0
USD